Page last updated: 2024-09-05

varenicline and Alcohol Abuse

varenicline has been researched along with Alcohol Abuse in 48 studies

Research

Studies (48)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (10.42)29.6817
2010's28 (58.33)24.3611
2020's15 (31.25)2.80

Authors

AuthorsStudies
Donato, S; Green, R; Ray, LA1
Kalin, NH1
Andreas, S; Batra, A; Gohlke, H; Kiefer, F; Klein, M; Kotz, D; Mons, U; Mühlig, S; Petersen, KU; Pötschke-Langer, M; Preuss, UW; Rustler, C; Rüther, T; Thomasius, R; Ulbricht, S1
Bendiks, S; Blokhina, E; Bryant, K; Cheng, DM; Freiberg, MS; Gnatienko, N; Hahn, J; Krupitsky, E; Lioznov, D; Patts, G; Samet, JH; So-Armah, K; Stein, MD; Tindle, HA; Yaroslavtseva, T1
Enders, CK; Nieto, SJ; O'Malley, SS; Ray, LA; Witkiewitz, K1
Paitoon, P; Phimarn, W; Sakhancord, R; Saramunee, K; Sungthong, B1
Deng, X; E, F; Guo, K; Li, X; Liang, S; Liu, W; Shang, X; Wang, Y; Wang, Z; Wu, Y; Yang, K; Zhou, L1
Cabrera-César, E; de Granda-Orive, JI; De Higes-Martínez, E; García Rueda, M; Jiménez-Ruiz, CA; Pastor-Esplá, E; Rábade-Castedo, C; Ramos-Pinedo, Á; Riesco-Miranda, JA; Signes-Costa Miñana, J1
Likhitsathain, S; Oon-Arom, A; Srisurapanont, M1
Gandhi, KD; Karpyak, VM; Kolla, BP; Mansukhani, MP; Schneekloth, TD; Wang, Z1
Chun, TH; Falk, DE; Fertig, JB; Litten, RZ; Miranda, R; Muvvala, SB; O'Malley, SS; Ryan, ML; Treloar Padovano, H; Wu, R1
Kenny, PJ; O'Brien, CP; Pierce, RC; Swinford-Jackson, SE; Unterwald, EM; Vanderschuren, LJMJ1
Grodin, EN; Ho, D; Ray, LA; Towns, B1
Burnette, EM; Green, R; Grodin, EN; Lim, AC; Miotto, K; Ray, LA1
Bold, KW; Fucito, LM; Gueorguieva, R; Haeny, AM; Montgomery, L; Muvvala, SB; O'Malley, SS; Wu, R; Zweben, A1
Chen, N; Guo, K; Li, J; Li, X; Li, Y; Yang, K1
McKee, SA; Moore, K; Oberleitner, L; Picciotto, MR; Roberts, W; Verplaetse, TL1
Fucito, L; O'Malley, SS; Piepmeier, ME; Zweben, A1
Dilley, JE; Filosa, NJ; Froehlich, JC; Nicholson, ER; Rademacher, LC; Smith, TN1
Higuchi, S; Matsushita, S; Mimura, M; Suzuki, T; Uchida, H; Ueno, F; Yokoyama, A1
Evins, AE; Kelly, JF1
Bold, KW; Fucito, LM; Gueorguieva, R; Jatlow, P; Muvvala, S; O'Malley, SS; Ockert, DM; Petrakis, I; Piepmeier, ME; Wu, R; Zweben, A1
Croghan, IT; Ebbert, JO; Hays, JT; Hurt, RD; Hurt, RT; Schroeder, DR1
McKee, SA; Roberts, W1
Lim, AC; Ray, LA; Roche, DJO1
Bold, KW; Fucito, LM; Gueorguieva, R; Muvvala, S; O'Malley, SS; Piepmeier, ME; Wu, R; Zweben, A1
Anton, RF; Falk, DE; Fertig, J; Hasin, DS; Johnson, B; Kranzler, HR; Litten, RZ; Mann, KF; Meulien, D; O'Malley, SS; Ryan, M; Slater, M; Witkiewitz, K1
Martin, RA; Rohsenow, DJ; Tidey, JW1
Abdul-Malak, Y; Ajagbe, TO; Batki, SL; Dimmock, JA; Meszaros, ZS; Wang, D1
Kampman, KM; Lynch, KG; O'Brien, CP; Pettinati, HM; Plebani, JG; Rennert, L1
Anton, RF; Henderson, S; Li, X; Myrick, H; Randall, PK; Schacht, JP1
Brody, A; Courtney, KE; Ghahremani, DG; London, ED; Miotto, K; Ray, LA1
Erwin, BL; Slaton, RM1
Ebert, S; Tetrault, JM1
Lieb, M; Soyka, M1
Higuchi, S; Kimura, M; Maesato, H; Matsushita, S; Mizukami, T; Nakayama, H; Sakuma, H; Takimura, T; Yokoyama, A; Yoneda, J; Yoshimura, A1
Asanovska, G; de Bejczy, A; Franck, J; Guterstam, J; Hammarberg, A; Isaksson, A; Löf, E; Söderpalm, B; Walther, L1
Aubin, HJ; Luquiens, A1
Klein, JW1
Dilley, JE; Filosa, NJ; Fischer, SM; Froehlich, JC; Nicholson, ER; Rademacher, LC; Smith, TN1
Nadeem, SS; Pirmoradi, P; Roshan, S1
Cocores, JA; Gold, MS1
Balchunas, E; Estevez, N; Harrison, EL; Krishnan-Sarin, S; McKee, SA; O'Malley, SS; Petrakis, IL; Picciotto, MR; Shi, J; Tetrault, JM1
Kuehn, BM1
Bartlett, SE; Chatterjee, S1
Croghan, IT; Ebbert, JO; Hays, JT; Hurt, RD; Schroeder, DR1
Bartlett, SE; Fields, HL; Kayser, AS; Mitchell, JM; Teague, CH1
Gould, TJ; Gulick, D1

Reviews

11 review(s) available for varenicline and Alcohol Abuse

ArticleYear
Efficacy of Varenicline in the Treatment of Alcohol Dependence: An Updated Meta-Analysis and Meta-Regression.
    International journal of environmental research and public health, 2023, 02-24, Volume: 20, Issue:5

    Topics: Alcoholic Intoxication; Alcoholism; Craving; Ethanol; Humans; Randomized Controlled Trials as Topic; Varenicline

2023
Efficacy and safety of antidepressants for smoking cessation: A systematic review and network meta-analysis.
    Addiction biology, 2023, Volume: 28, Issue:8

    Topics: Alcoholism; Antidepressive Agents; Bupropion; Humans; Network Meta-Analysis; Nortriptyline; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2023
Clinical Practice Guideline of Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on Pharmacological Treatment of Tobacco Dependence 2023.
    Archivos de bronconeumologia, 2023, Volume: 59, Issue:10

    Topics: Adolescent; Alcoholism; Bupropion; Female; Humans; Nicotinic Agonists; Pregnancy; Pulmonary Medicine; Smoking Cessation; Thoracic Surgery; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2023
Efficacy and acceptability of varenicline for alcoholism: A systematic review and meta-analysis of randomized-controlled trials.
    Drug and alcohol dependence, 2019, 12-01, Volume: 205

    Topics: Alcoholism; Humans; Nicotinic Agonists; Patient Satisfaction; Randomized Controlled Trials as Topic; Varenicline

2019
The Impact of Varenicline on Alcohol Consumption in Subjects With Alcohol Use Disorders: Systematic Review and Meta-Analyses.
    The Journal of clinical psychiatry, 2020, 02-25, Volume: 81, Issue:2

    Topics: Alcohol Drinking; Alcoholism; Humans; Nicotinic Agonists; Varenicline

2020
The effects of pharmacological interventions on smoking cessation in people with alcohol dependence: A systematic review and meta-analysis of nine randomized controlled trials.
    International journal of clinical practice, 2021, Volume: 75, Issue:11

    Topics: Alcoholism; Humans; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Varenicline

2021
Varenicline in the treatment of alcohol use disorders.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:11

    Topics: Alcohol Deterrents; Alcohol Drinking; Alcoholism; Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Tobacco Use Disorder; Varenicline

2014
Recent Developments in Pharmacotherapy of Alcoholism.
    Pharmacopsychiatry, 2015, Volume: 48, Issue:4-5

    Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Anticonvulsants; Baclofen; Humans; Naltrexone; Narcotic Antagonists; Pharmacogenetics; Randomized Controlled Trials as Topic; Taurine; Varenicline

2015
Feeding Two Birds with One Scone: The Case of Varenicline.
    Alcoholism, clinical and experimental research, 2015, Volume: 39, Issue:12

    Topics: Alcoholism; Clinical Trials as Topic; Dopamine; Humans; Nicotinic Agonists; Smoking; Varenicline

2015
Pharmacotherapy for Substance Use Disorders.
    The Medical clinics of North America, 2016, Volume: 100, Issue:4

    Topics: Age Factors; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Buprenorphine; Bupropion; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2016
Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.
    CNS & neurological disorders drug targets, 2010, Volume: 9, Issue:1

    Topics: Alcohol-Induced Disorders, Nervous System; Alcoholism; Animals; Benzazepines; Brain; Humans; Mecamylamine; Neurons; Nicotinic Agonists; Nicotinic Antagonists; Quinoxalines; Receptors, Nicotinic; Tobacco Use Disorder; Varenicline

2010

Trials

20 trial(s) available for varenicline and Alcohol Abuse

ArticleYear
Alcohol use disorder severity moderates clinical response to varenicline.
    Alcoholism, clinical and experimental research, 2021, Volume: 45, Issue:9

    Topics: Adult; Aged; Alcohol Drinking; Alcoholism; Craving; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Quality of Life; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult

2021
Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use: A Randomized Clinical Trial.
    JAMA network open, 2022, 08-01, Volume: 5, Issue:8

    Topics: Adult; Alcoholism; Alkaloids; Azocines; Benzazepines; Female; HIV Infections; Humans; Male; Nicotine; Nicotinic Agonists; Quinolizines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2022
Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels.
    Alcoholism, clinical and experimental research, 2022, Volume: 46, Issue:12

    Topics: Alcohol Drinking; Alcoholism; Double-Blind Method; Humans; Naltrexone; Treatment Outcome; Varenicline; World Health Organization

2022
Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.
    Alcoholism, clinical and experimental research, 2020, Volume: 44, Issue:7

    Topics: Adult; Aged; Alcohol Drinking; Alcoholism; Craving; Cues; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Treatment Outcome; Varenicline; Young Adult

2020
A novel human laboratory model for screening medications for alcohol use disorder.
    Trials, 2020, Nov-23, Volume: 21, Issue:1

    Topics: Alcohol Drinking; Alcoholism; Humans; Laboratories; Naltrexone; Varenicline

2020
The clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial.
    Journal of substance abuse treatment, 2017, Volume: 77

    Topics: Adult; Alcoholism; Combined Modality Therapy; Double-Blind Method; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Patient Satisfaction; Smoking; Smoking Cessation; Surveys and Questionnaires; Varenicline

2017
Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial.
    JAMA psychiatry, 2018, 02-01, Volume: 75, Issue:2

    Topics: Adult; Alcoholism; Combined Modality Therapy; Comorbidity; Double-Blind Method; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Patient Care Team; Sex Factors; Smoking Cessation; Treatment Outcome; Varenicline

2018
Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial.
    Drug and alcohol dependence, 2018, 03-01, Volume: 184

    Topics: Adult; Aged; Alcohol Drinking; Alcoholism; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Smokers; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult

2018
Effects of varenicline on cognitive performance in heavy drinkers: Dose-response effects and associations with drinking outcomes.
    Experimental and clinical psychopharmacology, 2018, Volume: 26, Issue:1

    Topics: Adult; Alcohol Drinking; Alcoholism; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Memory, Short-Term; Nicotinic Agonists; Reaction Time; Varenicline; Young Adult

2018
Longitudinal Findings from a Randomized Clinical Trial of Varenicline for Alcohol Use Disorder with Comorbid Cigarette Smoking.
    Alcoholism, clinical and experimental research, 2019, Volume: 43, Issue:5

    Topics: Adult; Alcoholism; Cigarette Smoking; Comorbidity; Double-Blind Method; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Smoking Cessation; Smoking Cessation Agents; Varenicline

2019
Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.
    JAMA psychiatry, 2019, 04-01, Volume: 76, Issue:4

    Topics: Adult; Alcohol Abstinence; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Female; Humans; Male; Middle Aged; Naltrexone; Risk Assessment; Topiramate; Varenicline

2019
Smokers with opioid use disorder may have worse drug use outcomes after varenicline than nicotine replacement.
    Journal of substance abuse treatment, 2019, Volume: 104

    Topics: Adult; Alcoholism; Comorbidity; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Outcome Assessment, Health Care; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline

2019
Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.
    Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:2

    Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline

2013
Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence.
    Drug and alcohol dependence, 2013, Dec-01, Volume: 133, Issue:2

    Topics: Adult; Affect; Alcoholism; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Pilot Projects; Quinoxalines; Sample Size; Smoking; Socioeconomic Factors; Treatment Outcome; Varenicline

2013
Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals.
    Psychopharmacology, 2014, Volume: 231, Issue:18

    Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Brain; Brain Mapping; Craving; Cues; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Motivation; Nicotinic Agonists; Pilot Projects; Quinoxalines; Reward; Varenicline; Young Adult

2014
Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings.
    The American journal of drug and alcohol abuse, 2015, Volume: 41, Issue:1

    Topics: Adult; Alcoholism; Benzazepines; Brain; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline

2015
Varenicline for treatment of alcohol dependence: a randomized, placebo-controlled trial.
    Alcoholism, clinical and experimental research, 2015, Volume: 39, Issue:11

    Topics: Adult; Aged; Alcoholism; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Single-Blind Method; Sweden; Treatment Outcome; Varenicline

2015
Varenicline reduces alcohol self-administration in heavy-drinking smokers.
    Biological psychiatry, 2009, Jul-15, Volume: 66, Issue:2

    Topics: Adult; Alcoholism; Benzazepines; Central Nervous System Depressants; Double-Blind Method; Ethanol; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking; Varenicline; Young Adult

2009
Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot study.
    Journal of substance abuse treatment, 2011, Volume: 40, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Alcoholism; Behavior Therapy; Benzazepines; Comorbidity; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking Cessation; Temperance; Time Factors; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult

2011
Varenicline decreases alcohol consumption in heavy-drinking smokers.
    Psychopharmacology, 2012, Volume: 223, Issue:3

    Topics: Adult; Alcohol Drinking; Alcoholism; Benzazepines; Double-Blind Method; Drug Administration Schedule; Female; Health Records, Personal; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult

2012

Other Studies

17 other study(ies) available for varenicline and Alcohol Abuse

ArticleYear
Insights Into Improving Clinical Outcomes Across Psychiatric Disorders and Medical Comorbidities.
    The American journal of psychiatry, 2021, 09-01, Volume: 178, Issue:9

    Topics: Alcoholism; Anorexia Nervosa; Attention Deficit Disorder with Hyperactivity; Comorbidity; Humans; Mental Disorders; Methadone; Naltrexone; Narcotics; Patient Outcome Assessment; Schizophrenia; Smoking; Varenicline

2021
S3 Guideline "Smoking and Tobacco Dependence: Screening, Diagnosis, and Treatment" - Short Version.
    European addiction research, 2022, Volume: 28, Issue:5

    Topics: Adolescent; Alcoholism; Female; Humans; Pregnancy; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2022
The Persistent Challenge of Developing Addiction Pharmacotherapies.
    Cold Spring Harbor perspectives in medicine, 2021, 11-01, Volume: 11, Issue:11

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Bupropion; Central Nervous System Stimulants; Cocaine-Related Disorders; Drug Therapy; Humans; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Smoking Cessation Agents; Substance-Related Disorders; Varenicline

2021
Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers.
    Drug and alcohol dependence, 2021, 08-01, Volume: 225

    Topics: Alcohol Drinking; Alcoholism; Cues; Double-Blind Method; Humans; Naltrexone; Smokers; Varenicline

2021
The effect of varenicline on smoking and drinking outcomes among Black and White adults with alcohol use disorder and co-occurring cigarette smoking: A secondary analysis of two clinical trials.
    Addictive behaviors, 2021, Volume: 122

    Topics: Adult; Alcoholism; Cigarette Smoking; Double-Blind Method; Female; Humans; Male; Smoking; Smoking Cessation; Treatment Outcome; Varenicline

2021
Effects of varenicline on alcohol self-administration and craving in drinkers with depressive symptoms.
    Journal of psychopharmacology (Oxford, England), 2017, Volume: 31, Issue:7

    Topics: Adult; Alcohol Drinking; Alcoholism; Comorbidity; Craving; Depression; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Outcome Assessment, Health Care; Varenicline

2017
Varenicline Reduces Alcohol Intake During Repeated Cycles of Alcohol Reaccess Following Deprivation in Alcohol-Preferring (P) Rats.
    Alcoholism, clinical and experimental research, 2017, Volume: 41, Issue:8

    Topics: Alcohol Abstinence; Alcohol Drinking; Alcoholism; Animals; Ethanol; Male; Rats; Self Administration; Varenicline

2017
Psychotic Symptoms Associated With Varenicline in a Patient With Alcohol and Nicotine Dependence: A Case Report.
    Journal of clinical psychopharmacology, 2017, Volume: 37, Issue:5

    Topics: Adult; Alcoholism; Humans; Male; Nicotinic Agonists; Psychoses, Substance-Induced; Tobacco Use Disorder; Varenicline

2017
A Call to Action for Treatment of Comorbid Tobacco and Alcohol Dependence.
    JAMA psychiatry, 2018, 02-01, Volume: 75, Issue:2

    Topics: Alcoholism; Cigarette Smoking; Comorbidity; Humans; Nicotiana; Varenicline

2018
Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers.
    Journal of studies on alcohol and drugs, 2018, Volume: 79, Issue:6

    Topics: Adult; Alcohol Drinking; Alcoholism; Cigarette Smoking; Craving; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Random Allocation; Smokers; Smoking Cessation; Stress, Psychological; Varenicline; Young Adult

2018
[Varenicline, an optional treatment for alcohol dependence syndrome in smokers or non-smokers].
    Revue medicale suisse, 2014, Oct-08, Volume: 10, Issue:445

    Topics: Alcoholism; Benzazepines; Humans; Multicenter Studies as Topic; Nicotinic Agonists; Pilot Projects; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Varenicline

2014
[Concurrent inpatient smoking cessation and alcohol abstinence programs for alcoholics and their outcomes].
    Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence, 2014, Volume: 49, Issue:6

    Topics: Adult; Aged; Alcohol Abstinence; Alcoholism; Benzazepines; Cognitive Behavioral Therapy; Female; Humans; Inpatients; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline; Young Adult

2014
Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism.
    Alcoholism, clinical and experimental research, 2016, Volume: 40, Issue:9

    Topics: Alcohol Drinking; Alcoholism; Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Male; Models, Animal; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Rats; Rodentia; Treatment Outcome; Varenicline

2016
Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Sep-01, Volume: 65, Issue:17

    Topics: Adult; Alcoholism; Benzazepines; Depressive Disorder, Major; Humans; Male; Mental Disorders; Nervous System Diseases; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline

2008
Varenicline, appetite, and weight reduction.
    The Journal of neuropsychiatry and clinical neurosciences, 2008,Fall, Volume: 20, Issue:4

    Topics: Aged; Alcoholism; Benzazepines; Female; Humans; Psychiatric Status Rating Scales; Quinoxalines; Smoking Cessation; Varenicline; Weight Loss

2008
Findings on alcohol dependence point to promising avenues for targeted therapies.
    JAMA, 2009, Apr-22, Volume: 301, Issue:16

    Topics: Alcoholism; Animals; Benzazepines; Humans; Naltrexone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Nicotinic Agonists; Pharmacogenetics; Pyridines; Quinoxalines; Receptors, Corticotropin-Releasing Hormone; Receptors, Opioid, mu; Stress, Psychological; Triazoles; Varenicline

2009
Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice.
    Neurobiology of learning and memory, 2008, Volume: 90, Issue:1

    Topics: Acetylcholine; Alcoholism; Animals; Benzazepines; Central Nervous System Depressants; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Freezing Reaction, Cataleptic; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Quinoxalines; Smoking Cessation; Varenicline

2008